Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors

BACKGROUND: Met and HER-2 are proto-oncogenes encoding receptor tyrosine kinase c-Met and HER-2, respectively. Hepatocyte growth factor (HGF) is a ligand of c-Met. The frequency of c-Met, HGF, and HER-2 expressions in gastric cancer and their association with other clinicopathological factors have n...

Descripción completa

Detalles Bibliográficos
Autores principales: Yıldız, Yetkin, Sokmensuer, Cenk, Yalcin, Suayib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036569/
https://www.ncbi.nlm.nih.gov/pubmed/27703380
http://dx.doi.org/10.2147/OTT.S107946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036569/
https://www.ncbi.nlm.nih.gov/pubmed/27703380
http://dx.doi.org/10.2147/OTT.S107946

Ejemplares similares